0000000000977579

AUTHOR

S. Arndt

showing 12 related works from this author

Gastrointestinal symptoms and association with medication use patterns, adherence, treatment satisfaction, quality of life, and resource use in osteo…

2016

The Medication Use Patterns, Treatment Satisfaction, and Inadequate Control of Osteoporosis Study (MUSIC-OS) is a prospective, observational study of women with osteoporosis in Europe and Canada. At baseline, patients with gastrointestinal symptoms reported lower adherence to osteoporosis treatment, treatment satisfaction, and health-related quality of life, than those without gastrointestinal symptoms. INTRODUCTION: The aim of the study was to examine gastrointestinal (GI) symptoms and the association between GI symptoms and treatment adherence, treatment satisfaction, and health-related quality of life (HRQoL) among osteoporotic women in Europe and Canada. METHODS: Baseline results are re…

Gastrointestinal DiseasesEndocrinology Diabetes and MetabolismHealth-related quality of lifeOsteoporosisFRACTURE RISKRISEDRONATE0302 clinical medicineEndocrinologyQuality of lifeBack pain030212 general & internal medicineProspective StudiesHEALTH PLANProspective cohort studyALENDRONATEOsteoporosis PostmenopausalPOPULATIONeducation.field_of_studyBone Density Conservation AgentsDiphosphonatesBISPHOSPHONATE THERAPYSettore MED/34 - Medicina Fisica E RiabilitativaTRACT SAFETYBisphosphonatesMiddle AgedEuropeDiabetes and MetabolismPOSTMENOPAUSAL WOMENPatient SatisfactionHealth ResourcesFemaleOriginal ArticlePostmenopausalmedicine.symptomBisphosphonates; Gastrointestinal; Health-related quality of life; Osteoporosis; Postmenopausal; Treatment satisfaction; Aged; Bone Density Conservation Agents; Canada; Diphosphonates; Europe; Female; Gastrointestinal Diseases; Health Resources; Humans; Medication Adherence; Middle Aged; Osteoporosis Postmenopausal; Patient Satisfaction; Prospective Studies; Psychometrics; Quality of Life; Endocrinology Diabetes and Metabolismmedicine.medical_specialtyCanadaGastrointestinalPsychometricsPopulation030209 endocrinology & metabolismNOMedication Adherence03 medical and health sciencesInternal medicinemedicineHumanseducationBisphosphonates; Gastrointestinal; Health-related quality of life; Osteoporosis; Postmenopausal; Treatment satisfaction; Aged; Bone Density Conservation Agents; Canada; Diphosphonates; Europe; Female; Gastrointestinal Diseases; Health Resources; Humans; Medication Adherence; Middle Aged; Osteoporosis Postmenopausal; Patient Satisfaction; Prospective Studies; Psychometrics; Quality of LifeAgedTreatment satisfactionbusiness.industryPERSISTENCEbisphosphonates gastrointestyinal osteoporosis postmenopausal treatment satisfactionBisphosphonates; Gastrointestinal; Health-related quality of life; Osteoporosis; Postmenopausal; Treatment satisfactionmedicine.diseaseRheumatologyCLINICAL-PRACTICEOrthopedic surgeryQuality of LifeOsteoporosisObservational studybusinessBisphosphonates; Gastrointestinal; Health-related quality of life; Osteoporosis; Postmenopausal; Treatment satisfaction; Endocrinology Diabetes and Metabolism
researchProduct

CCDC 170823: Experimental Crystal Structure Determination

2002

Related Article: S.Arndt, A.Trifonov, T.P.Spaniol, J.Okuda, M.Kitamura, T.Takahashi|2002|J.Organomet.Chem.|647|158|doi:10.1016/S0022-328X(01)01421-8

Space GroupCrystallography(2-Thienyl)-(tetrahydrofuran)-(eta^5^-t-butylamido(dimethyl)silylmethyl(tetramethyl)-cyclopentadienyl)-yttriumCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 170822: Experimental Crystal Structure Determination

2002

Related Article: S.Arndt, A.Trifonov, T.P.Spaniol, J.Okuda, M.Kitamura, T.Takahashi|2002|J.Organomet.Chem.|647|158|doi:10.1016/S0022-328X(01)01421-8

Space GroupCrystallographyCrystal SystemCrystal StructureCell Parameters(Pyrrolyl)-(12-dimethoxyethane)-(eta^5^-t-butylamido(dimethyl)silyl(tetramethyl)-cyclopentadienyl)-yttriumExperimental 3D Coordinates
researchProduct

CCDC 170821: Experimental Crystal Structure Determination

2002

Related Article: S.Arndt, A.Trifonov, T.P.Spaniol, J.Okuda, M.Kitamura, T.Takahashi|2002|J.Organomet.Chem.|647|158|doi:10.1016/S0022-328X(01)01421-8

Space GroupCrystallographyCrystal SystemCrystal Structure(2-Furanyl)-(12-dimethoxyethane)-(eta^5^-t-butylamido(dimethyl)silyl(tetramethyl)-cyclopentadienyl)-yttriumCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 211480: Experimental Crystal Structure Determination

2004

Related Article: S.Arndt, P.M.Zeimentz, T.P.Spaniol, J.Okuda, M.Honda, K.Tatsumi|2003|Dalton Trans.||3622|doi:10.1039/b305964b

Space GroupCrystallographyCrystal SystemCrystal StructureCell Parameters(12-Crown-4)-tris(trimethylsilylmethyl)-yttriumExperimental 3D Coordinates
researchProduct

CCDC 179962: Experimental Crystal Structure Determination

2002

Related Article: S.Arndt, T.P.Spaniol, J.Okuda|2002|Chem.Commun.||896|doi:10.1039/b201613n

Space GroupCrystallographyCrystal SystemCrystal StructureCell Parameters(1471013-Pentaoxacyclopentadecane)-bis((trimethylsilyl)methyl)-lutetium(iii) triphenyl((trimethylsilyl)methyl)borate 12-dichloroethane solvateExperimental 3D Coordinates
researchProduct

CCDC 216055: Experimental Crystal Structure Determination

2004

Related Article: S.Arndt, T.P.Spaniol, J.Okuda|2003|Angew.Chem.,Int.Ed.|42|5075|doi:10.1002/anie.200352532

Space GroupCrystallographyMethyl-hexakis(tetrahydrofuran)-yttrium bis(tetraphenylborate) tetrahydrofuran solvateCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 179961: Experimental Crystal Structure Determination

2002

Related Article: S.Arndt, T.P.Spaniol, J.Okuda|2002|Chem.Commun.||896|doi:10.1039/b201613n

Space GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates(Tetrahydrofuran)-(14710-tetraoxacyclododecane)-bis((trimethylsilyl)methyl)-lutetium(iii) triphenyl((trimethylsilyl)methyl)borate
researchProduct

CCDC 170820: Experimental Crystal Structure Determination

2002

Related Article: S.Arndt, A.Trifonov, T.P.Spaniol, J.Okuda, M.Kitamura, T.Takahashi|2002|J.Organomet.Chem.|647|158|doi:10.1016/S0022-328X(01)01421-8

Space GroupCrystallographybis((mu~2~-2-Thienyl)-(eta^5^-t-butylamido(dimethyl)silyl-tetramethyl-cyclopentadienyl)-yttrium)Crystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 216054: Experimental Crystal Structure Determination

2004

Related Article: S.Arndt, T.P.Spaniol, J.Okuda|2003|Angew.Chem.,Int.Ed.|42|5075|doi:10.1002/anie.200352532

Space GroupCrystallographyCrystal SystemCrystal StructureCell Parametersbis(Trimethylsilylmethyl)-tetrakis(tetrahydrofuran)-yttrium tetrakis(trimethylsilylmethyl)aluminateExperimental 3D Coordinates
researchProduct

CCDC 179963: Experimental Crystal Structure Determination

2002

Related Article: S.Arndt, T.P.Spaniol, J.Okuda|2002|Chem.Commun.||896|doi:10.1039/b201613n

(147101316-Hexaoxacyclooctadecane)-bis((trimethylsilyl)methyl)-lutetium(iii) triphenyl((trimethylsilyl)methyl)borate 12-dichloroethane solvateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 211481: Experimental Crystal Structure Determination

2004

Related Article: S.Arndt, P.M.Zeimentz, T.P.Spaniol, J.Okuda, M.Honda, K.Tatsumi|2003|Dalton Trans.||3622|doi:10.1039/b305964b

Space GroupCrystallography(12-Crown-4)-tris(trimethylsilylmethyl)-lutetiumCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct